Cost Plus Drugs expands portfolio with Starjemza
Cost Plus Drugs Adds Starjemza to Portfolio Mark Cuban Cost Plus Drug Company announced the inclusion of Starjemza, a biosimilar medication, in its expanding lineup of affordable prescript…
Cost Plus Drugs Adds Starjemza to Portfolio Mark Cuban Cost Plus Drug Company announced the inclusion of Starjemza, a biosimilar medication, in its expanding lineup of affordable prescript…
Hong Kong Sixes 2025: India vs Kuwait The highly anticipated Hong Kong Sixes 2025 clash between India and Kuwait will be streamed live on…
Raptors vs. Nets Prediction Game Overview The Brooklyn Nets (1-9) are heavy underdogs by 10.5 points as they try to end a five-…
Comerica Declares Dividends on Common and Preferred Stock The Board of Directors of Comerica Incorporated (NYSE: CMA) announced a quarter…
Remembrance Day and Armistice Day Message from the Chair of the Council This Sunday, 9 November, marks Remembrance Sunday, honoring the c…
Suspicious Package Causes Evacuation at Joint Base Andrews A suspicious package at Joint Base Andrews near Washington led to several peop…
Florida’s DOGE Releases Public University Spending Analysis The state of Florida published the findings of an efficiency study on its pub…
Port Macquarie Laneway Transformed for Hideaway Festival This November, Phillips Lane in Port Macquarie will come alive as it hosts the in…
The Standard Remains the Standard: T.J. Watt Leads Steelers’ Midseason Honors The Pittsburgh Steelers have once again shaped their identi…